Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
- Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung CancerNot Yet Recruiting
Sponsor: National Taiwan University Hospital
Non-Small Cell Lung Cancer
- Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)Active Not Recruiting
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Small Cell Lung Cancer Extensive Stage
France
Sponsor: MacroGenics
Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer · Squamous Cell Carcinoma of Head and Neck
United States, Australia, United Kingdom
- Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung DiseaseNot Yet Recruiting
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Non Small Cell Lung Cancer Metastatic · Interstitial Lung Disease (ILD)
France
Sponsor: The University of Hong Kong
Lung Cancer (Diagnosis) · Acupressure · Coughing · Symptom Cluster
China, Hong Kong
- XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Active Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Pancreatic Adenocarcinoma Metastatic · Lung Cancer (NSCLC) · Ovarian Cancer · Colorectal Cancer Metastatic
China
- Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: Servier Bio-Innovation LLC
Non-small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Austria, Belgium +9 more
Sponsor: M.D. Anderson Cancer Center
Lung Non-Small Cell Carcinoma
United States
Sponsor: Genentech, Inc.
Non-small Cell Lung Cancer
United States
- Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)Active Not Recruiting
Sponsor: Tang-Du Hospital
Non-small Cell Lung Cancer
China
- Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLCRecruiting
Sponsor: Swiss Cancer Institute
NSCLC · NSCLC (Advanced Non-small Cell Lung Cancer)
Switzerland
- Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLCNot Yet Recruiting
Sponsor: Se-Hoon Lee
Non Small Cell Lung Cancer
- Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung CancerActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Metastatic Lung Non-Small Cell Carcinoma · Recurrent Lung Non-Small Cell Carcinoma · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
Sponsor: Memorial Sloan Kettering Cancer Center
Extensive-stage Small-cell Lung Cancer
United States
- ENCOrafenib With Binimetinib in bRAF NSCLCActive Not Recruiting
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Non Small Cell Lung Cancer · BRAF V600E
France
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumor
United States, Canada, Japan
Sponsor: Bayer
Advanced Solid Tumors · Non-small Cell Lung Cancer
United States, Australia, China, Israel, South Korea +1 more
Sponsor: VA Office of Research and Development
Lung Cancer
United States
- CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerActive Not Recruiting
Sponsor: Roswell Park Cancer Institute
Advanced Head and Neck Squamous Cell Carcinoma · Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · PD-L1 Positive
United States
Sponsor: Bristol-Myers Squibb
Non-Small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Austria, Belgium +31 more
Sponsor: Multitude Therapeutics Inc.
Advanced Non-small Cell Lung Cancer (NSCLC)
China
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Pleural Mesotheliomas
France
Sponsor: Wake Forest University Health Sciences
Non-small Cell Lung Cancer
United States
Sponsor: Rigel Pharmaceuticals
NSCLC (Non-small Cell Lung Cancer) · Thyroid Cancer · Solid Tumor Malignancies · Advanced Malignancies
Spain
Sponsor: Bristol-Myers Squibb
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
United States, Argentina, Australia, Austria, Belgium +29 more